Phase 3 Non-cystic Fibrosis Bronchiectasis Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Haisco Pharmaceutical Group Co., Ltd.669 enrolled1 locationNCT07616375
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Haisco Pharmaceutical Group Co., Ltd.669 enrolled2 locationsNCT06660992